IP Library Granted Patent US 9,808,620
Granted Patent B2
US 9,808,620 · App. 15/491,910 · Granted Nov 7, 2017

Method and apparatus for treating restless legs syndrome

Inventor: Steven Thomas Kent (Portola Valley, CA)
Assignee: INVICTA MEDICAL, INC.
A61N1/36003A61N1/0456A61N1/0484A61N1/36014
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,808,620
App. No.
15/491,910
Granted
Nov 7, 2017
Kind
B2
Abstract

Apparatuses and methods are disclosed that may be used to treat one or more restless leg syndrome (RLS) symptoms of a patient. One example method may include generating first and second stimulation waveforms using a waveform generator; electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using a number of electrodes; damping or interfering with electrical signals transmitted from the patient's brain to the patient's legs via a femoral nerve of the patient using the electrical stimulation; and reducing the one or more symptoms of RLS based on damping or interfering with the electrical signals transmitted from the patient's brain.

Claims (60)

1. A method for treating one or more restless leg syndrome (RLS) symptoms of a patient, the method comprising:

generating first and second stimulation waveforms using a waveform generator;

electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using at least four electrodes; and

damping or interfering with electrical signals transmitted along the patient's femoral nerve to the patient's legs based on the electrical stimulation, wherein:

a first electrode is positioned on a left portion of the patient's lumbar region and configured to receive the first stimulation waveform on a first channel;

a second electrode is positioned on a right portion of the patient's lumbar region and configured to receive the second stimulation waveform on a second channel separate from the first channel;

a third electrode is positioned over a hamstring of the patient's right leg and configured to receive the first stimulation waveform on the first channel; and

a fourth electrode is positioned over a hamstring of the patient's left leg and configured to receive the second stimulation waveform on the second channel.

2. The method of claim 1 , wherein each of the first and second stimulation waveforms has a frequency of 250 Hz, a pulse width of 250 microseconds, and a current between 8 and 12 milliamps.

3. The method of claim 1 , wherein the electrically stimulating comprises:

inducing a first electrical current to transcutaneously flow between the first electrode and the third electrode based on the first stimulation waveform; and

inducing a second electrical current to transcutaneously flow between the second electrode and the fourth electrode based on the second stimulation waveform.

4. The method of claim 3 , wherein the first electrical current flows in a first diagonal direction across the sacral region of the patient, and the second electrical current flows in a second diagonal direction across the sacral region of the patient.

5. The method of claim 4 , wherein the first diagonal direction is orthogonal to the second diagonal direction.

6. The method of claim 4 , wherein the first and second electrical currents are configured to electrically stimulate the femoral nerve or one or more nerves exiting from the patient's spinal column.

7. The method of claim 3 , wherein the number of electrodes further comprises fifth, sixth, seventh, and eighth electrodes, and the electrically stimulating further comprises:

inducing a third electrical current to transcutaneously flow between the fifth electrode and the eighth electrode based on the first stimulation waveform; and

inducing a fourth electrical current to transcutaneously flow between the sixth electrode and the seventh electrode based on the second stimulation waveform.

8. The method of claim 7 , wherein:

the fifth electrode is positioned on the left portion of the patient's lumbar region above the first electrode;

the sixth electrode is positioned on the right portion of the patient's lumbar region above the second electrode;

the seventh electrode is positioned over the hamstring of the patient's right leg and below the fourth electrode; and

the eight electrode is positioned over the hamstring of the patient's left leg and below the third electrode.

9. The method of claim 7 , wherein the first and second electrical signals comprise a first set of transcutaneously applied electrical currents, and the third and fourth electrical signals comprise a second set of transcutaneously applied electrical currents that overlap the first set of transcutaneously applied electrical currents.

10. The method of claim 1 , wherein:

the first electrode is positioned between the patient's L4 vertebrae and S2 vertebrae; and

the second electrode is positioned between the patient's L4 vertebrae and S2 vertebrae.

11. The method of claim 10 , wherein the first electrical current is configured to flow from the first electrode to the third electrode, and the second electrical current is configured to flow from the second electrode to the fourth electrode.

12. The method of claim 10 , wherein the first electrical current is configured to flow from the third electrode to the first electrode, and the second electrical current is configured to flow from the fourth electrode to the second electrode.

13. The method of claim 1 , wherein the electrical stimulation is configured to target the femoral nerve.

14. The method of claim 1 , further comprising:

reducing one or more symptoms of RLS based on damping or interfering with the electrical signals.

15. The method of claim 1 , further comprising:

selectively adjusting the first and second stimulation waveforms based on feedback information indicating involuntary limb movements of the patient.

16. The method of claim 1 , further comprising:

receiving, from a wireless communication device, one or more control signals configured to selectively start, stop, or adjust electrical stimulation of the portion of the sacral region.

17. The method of claim 16 , further comprising:

transmitting feedback information from the number of electrodes to the wireless communication device, wherein the control signals are based at least in part on the feedback information.

18. The method of claim 1 , wherein at least some of the electrodes are disposed within a wearable garment.

19. A method for treating one or more restless leg syndrome (RLS) symptoms of a patient, the method comprising:

generating first and second stimulation waveforms using a waveform generator;

electrically stimulating at least a portion of a sacral region of the patient, based on the first and second stimulation waveforms, using at least four electrodes;

damping or interfering with electrical signals transmitted along the patient's femoral nerve to the patient's legs based on the electrical stimulation; and

reducing one or more symptoms of RLS based on the damping or interfering with the electrical signals, wherein:

a first electrode is positioned on a left portion of the patient's lumbar region and configured to receive the first stimulation waveform on a first channel;

a second electrode is positioned on a right portion of the patient's lumbar region and configured to receive the second stimulation waveform on a second channel separate from the first channel;

a third electrode is positioned over a quadricep of the patient's right leg and configured to receive the first stimulation waveform on the first channel; and

a fourth electrode is positioned over a quadricep of the patient's left leg and configured to receive the second stimulation waveform on the second channel.

20. The method of claim 19 , wherein the first electrical current is configured to flow from the first electrode to the third electrode, and the second electrical current is configured to flow from the second electrode to the fourth electrode.

21. The method of claim 20 , wherein the first electrical current is configured to flow across the patient's sacral region and around the patient's right hip, and the second electrical current is configured to flow across the patient's sacral region and around the patient's left hip.

22. The method of claim 19 , wherein:

the first electrode is positioned between the patient's L4 vertebrae and S2 vertebrae; and

the second electrode is positioned between the patient's L4 vertebrae and S2 vertebrae.

23. The method of claim 19 , wherein the electrical stimulation is configured to target the femoral nerve.

24. The method of claim 19 , further comprising:

selectively adjusting the first and second stimulation waveforms based on feedback information indicating involuntary limb movements of the patient.

25. The method of claim 19 , further comprising:

receiving, from a wireless communication device, one or more control signals configured to selectively start, stop, or adjust electrical stimulation of the portion of the sacral region.

26. The method of claim 25 , further comprising:

transmitting feedback information from the number of electrodes to the wireless communication device, wherein the control signals are based at least in part on the feedback information.

Assignments (4)
CHANGE OF NAME Recorded May 4, 2026
From: INVICTA MEDICAL, INC.
To: RESTERA, INC.
Reel/Frame 075522/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2025
From: APHELION CAPITAL, LLC, AS COLLATERAL AGENT
To: INVICTA MEDICAL, INC.
Reel/Frame 072014/0302 →
SECURITY INTEREST Recorded Feb 11, 2025
From: INVICTA MEDICAL, INC.
To: APHELION CAPITAL, LLC, AS COLLATERAL AGENT
Reel/Frame 070176/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2017
From: KENT, STEVEN THOMAS
To: INVICTA MEDICAL, INC.
Reel/Frame 042071/0106 →
Continuity (3)
Division 15173649 · Jun 4, 2016
Provisional Application 62171218 · Jun 4, 2015
Related Publication 20170216586A1 · Aug 3, 2017